Replies to post #310226 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

The only information that might still be important to some, is to accept that <= 21 and maybe about 10 P2a AD trial extensions patients are potentially still on A2-73 - as far as Missling can guess.

FACT! There are NO other SAS prescriptions flying around to anyone else!